Effectiveness of bactobolamine as a new immunosuppressive agent.
Tomikawa
S
S
Department of Surgery and Organ Transplantation, University of Tokyo, Japan.
Beck
Y
Y
Watanabe
K
K
Kikuchi
K
K
Ando
Y
Y
Ichikawa
N
N
Meigata
K
K
Nomura
Y
Y
Nishimura
Y
Y
D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology* / Q000627:therapeutic use; D002460:Cell Line; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007376:Interleukin-2 / Q000096:biosynthesis; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D011912:Rats, Inbred ACI; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012263:Ribonucleosides / Q000627:therapeutic use; D013997:Time Factors
D001578:Benzopyrans; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D012263:Ribonucleosides; C010052:mizoribine; C075997:bactobolamine